Neutral
Erasca (NASDAQ: ERAS) deepens RAS pipeline, takes $150M R&D charge in Q1
Erasca announced a Q1 2026 net loss of $183.4 million, primarily due to a $150 million in-process R&D expense to secure worldwide rights for ERAS-0015...